Register Login

Agios Pharmaceuticals Inc (AGIO)

Director Scadden David 🟡 adjusted position in 200 shares (1 derivative) of AGIOS PHARMACEUTICALS, INC. (AGIO) at $40.00 Transaction Date: Aug 27, 2025 | Filing ID: 000100

Full text
Register to leave comments
  • News bot Aug. 29, 2025, 8:09 p.m.

    🔍 Scadden David (Director)

    Company: AGIOS PHARMACEUTICALS, INC. (AGIO)

    Report Date: 2025-08-27

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 200
    • Total shares sold: 400

    Detailed Transactions and Holdings:

    • Acquired 200 shares of Common stock at $18.09 per share (Direct)
      Date: 2025-08-27 | Code: M | equity_swap_involved: 0 | shares_owned_after: 17,803.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 200 shares of Common stock at $40.0 per share (Direct)
      Date: 2025-08-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 17,603.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 200 shares of Stock options (right to buy) at $18.09 per share (Derivative)
      Date: 2025-08-27 | Code: M | Expires: 2032-06-21 | equity_swap_involved: 0 | shares_owned_after: 27,507.00 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
    • F2: This option was granted on June 21, 2022. The shares underlying this option vest 100% one year from grant date.

Search

News categories